Trials / Completed
CompletedNCT00366730
Study of Nitazoxanide in the Treatment of Amebiasis in Children
Multi-Center, Double-Blind, Placebo-Controlled Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Entamoeba Histolytica in Children
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- Romark Laboratories L.C. · Industry
- Sex
- All
- Age
- 1 Year – 11 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effect of nitazoxanide suspension in treating diarrhea caused by Entamoeba histolytica in children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitazoxanide |
Timeline
- Start date
- 2004-02-01
- Completion
- 2005-11-01
- First posted
- 2006-08-21
- Last updated
- 2006-08-21
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT00366730. Inclusion in this directory is not an endorsement.